Stocktoria
Beta Bionics, Inc. BBNX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-01-30
Beta Bionics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Gross margin | 55.4% | 55.1% | 52.6% |
| Operating margin | -71.5% | -69.5% | -298.9% |
| Net margin | -73.0% | -84.1% | -367.6% |
| FCF margin | -56.1% | -79.3% | -273.8% |
| Return on assets | -22.3% | -36.6% | -40.1% |
| Return on equity | -25.5% | 22.3% | 21.7% |
| Current ratio | 8.66 | 6.29 | 9.77 |
| Revenue growth | 53.9% | 442.9% | — |
Source: SEC EDGAR filings · CIK 0001674632 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.